Indoco Remedies receives approval for Rasagiline tablets

07 Oct 2019 Evaluate

Indoco Remedies has received final approval for its Abbreviated New Drug Application (ANDA) for Rasagiline 0.5 mg and 1 mg tablets from the United States Food & Drug Administration (USFDA). Rasagiline is used for treatment of Parkinson's disease. The market size of this product in the US as per IMS 2018 data is $105 million.

This is the first ANDA approval for the company after receipt of warning letter in March 2017 for Goa plant II and III. The Company has 32 ANDAs pending for approval for different dosage forms from this site.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

328.00 -0.80 (-0.24%)
25-Apr-2024 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1503.70
Dr. Reddys Lab 6005.30
Cipla 1399.00
Zydus Lifesciences 933.15
Lupin 1595.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.